BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 14996709)

  • 1. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus.
    McManus DT; Olaru A; Meltzer SJ
    Cancer Res; 2004 Mar; 64(5):1561-9. PubMed ID: 14996709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
    Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
    United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical biomarkers in esophageal adenocarcinoma.
    Biondi A; Migliore M; Strano G; Vadala S; Tropea A; Basile F
    Front Biosci (Elite Ed); 2010 Jan; 2(2):489-94. PubMed ID: 20036895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
    Rudolph RE; Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
    J Natl Cancer Inst; 2003 May; 95(10):750-7. PubMed ID: 12759393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Biomarkers for Risk Stratification in Barrett's Esophagus.
    Souza RF; Spechler SJ
    Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):105-115. PubMed ID: 33213790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Risk in Barrett's Esophagus: A Clinical Review.
    Beydoun AS; Stabenau KA; Altman KW; Johnston N
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus and Barrett's carcinoma.
    von Rahden BH; Stein HJ; Siewert JR
    Curr Oncol Rep; 2003 May; 5(3):203-9. PubMed ID: 12667417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett's esophagus: clinical characteristics.
    Reynolds JC; Rahimi P; Hirschl D
    Gastroenterol Clin North Am; 2002 Jun; 31(2):441-60. PubMed ID: 12134612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention in Barrett's oesophagus.
    Baruah A; Buttar NS
    Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):151-65. PubMed ID: 25743463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
    Sostres C; Lacarta P; Lanas A
    Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?
    Konda VJA; Souza RF
    Curr Gastroenterol Rep; 2019 Mar; 21(4):14. PubMed ID: 30868278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who Deserves Endoscopic Screening for Esophageal Neoplasia?
    Blevins CH; Iyer PG
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):365-378. PubMed ID: 28577762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance.
    Saxena N; Inadomi JM
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):397-421. PubMed ID: 28577764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Barrett's esophagus: screening and prognosis].
    Mazzucchelli L; Wagner AC
    Ther Umsch; 2001 Mar; 58(3):158-64. PubMed ID: 11305154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus.
    Falk GW
    Gastroenterology; 2002 May; 122(6):1569-91. PubMed ID: 12016424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma.
    Bani-Hani K; Martin IG; Hardie LJ; Mapstone N; Briggs JA; Forman D; Wild CP
    J Natl Cancer Inst; 2000 Aug; 92(16):1316-21. PubMed ID: 10944553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular alterations in Barrett's esophagus and adenocarcinoma].
    Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):235-9. PubMed ID: 10379532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment.
    Brandtner AK; Quante M
    Scand J Clin Lab Invest Suppl; 2016; 245():S63-9. PubMed ID: 27467504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus in 2008: an update.
    Wood RK; Yang YX
    Keio J Med; 2008 Sep; 57(3):132-8. PubMed ID: 18854665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.